CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Total	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit Prior to Exploration Stage [Member]	Accumulated Deficit During Exploration Stage [Member]
Balance at Dec. 31, 2020	$ (47,829,437)	$ 183,939	$ 128	$ 74,008,636	$ (20,009,496)	$ (102,012,644)
Balance (in shares) at Dec. 31, 2020		183,938,549	128,000
Issuance of shares of common stock for consulting services (in shares)	9,528,689	3,836,475
Shares issued on conversion of preferred stock (in shares)		6,167,273	(128,000)
Shares issued on conversion of preferred stock	$ 7,680	$ 6,167	$ (128)	1,641	0	0
Shares issued in private placement	100,000	$ 0	$ 95	99,905	0	0
Shares issued in private placement (in shares)		0	95,000
Beneficial conversion feature on Convertible Series B Preferred Stock	60,738	$ 0	$ 0	60,738	0	0
Deemed dividend from beneficial conversion feature on Convertible Series B Preferred Stock	(60,738)	0	0	(60,738)	0	0
Shares issued for cashless exercise of options	0	$ 3,836		(3,836)	0
Shares issued for cashless exercise of options (in shares)		3,836,475
Shares issued to employee in lieu of bonus	58,140	$ 1,163	$ 0	56,977	0	0
Shares issued to employee in lieu of bonus (in shares)		1,162,791	0
Stock based compensation expense	3,943	$ 0	$ 0	3,943	0	0
Net Loss	(845,958)	$ 0	0	0	0	(845,948)
Shares issued as part of settlement of liability (in shares)		1,162,791
Issuance of shares of common stock for debt issuance cost (in shares)		58,140
Balance at Mar. 31, 2021	(48,505,632)	$ 195,105	$ 95	74,167,266	(20,009,496)	(102,858,602)
Balance (in shares) at Mar. 31, 2021		195,105,088	95,000
Balance at Dec. 31, 2021	(50,400,882)	$ 217,654	$ 262	74,686,581	(20,009,496)	105,295,883
Balance (in shares) at Dec. 31, 2021		217,655,150	262,000
Issuance of shares of common stock for consulting services	70,000	$ 10,000	$ 0	60,000	0	0
Issuance of shares of common stock for consulting services (in shares)		10,000,000	0
Shares issued on conversion of preferred stock (in shares)		20,164,153	(75,000)
Shares issued on conversion of preferred stock	$ 0	$ 20,164	$ (75)	(20,089)	0	0
Shares issued for cashless exercise of options (in shares)	0
Stock based compensation expense	$ 21,211	0	0	21,211	0	0
Net Loss	(1,115,665)	0	0	0	0	(1,115,665)
Shares issued as part of settlement of liability	53,778	$ 4,444	$ 0	49,334	0	0
Shares issued as part of settlement of liability (in shares)		4,444,444	0
Issuance of shares of common stock for debt issuance cost	1,740	$ 300	$ 0	1,440	0	0
Issuance of shares of common stock for debt issuance cost (in shares)		300,000	0
Balance at Mar. 31, 2022	$ (51,369,818)	$ 252,562	$ 187	$ 74,798,477	$ (20,009,496)	$ (106,411,548)
Balance (in shares) at Mar. 31, 2022		252,563,747	187,000